Towfique Raj, PhD
- ASSOCIATE PROFESSOR | Neuroscience
- ASSOCIATE PROFESSOR | Genetics and Genomic Sciences
- ASSOCIATE PROFESSOR | Neurology
Research Topics:
Alzheimer's Disease, Genetics, Genetics of Movement disorders, Genomics, Human Genetics and Genetic Disorders, Macrophage, Microglia, Parkinson's Disease, RNA Splicing & ProcessingTowfique Raj, PhD, is a principal investigator of the laboratory for functional genomics, a core faculty member in the Ronald M. Loeb Center for Alzheimer's Disease, an assistant professor in the Department of Neuroscience and the Department of Genetics and Genomic Sciences, and a member of the Icahn Genomics Institute at Icahn School of Medicine at Mount Sinai, New York. Dr. Raj received his PhD in genetics from Cambridge University and completed a postdoctoral fellowship at the Broad Institute of MIT and Harvard. Before joining Mount Sinai, Dr. Raj was an instructor of neurology at Harvard Medical School and a visiting scholar at Stanford University. Dr. Raj received the Gates-Cambridge Scholarship and NIH Ruth L. Kirschstein Research Service Award. In his research, he uses computational and experimental approaches to understand the genetic factors driving neurodegenerative diseases with the ultimate goal of finding a cure.
Lab Website: Raj Lab
Publications: https://scholar.google.com/citations?user=_1soEyEAAAAJ&hl=en
Education
PhD, University of Cambridge
Postdoctoral Fellow, Brigham and Women's Hospital and Harvard Medical School
Postdoctoral Fellow, Broad Institute
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Dr. Raj did not report having any of the following types of financial relationships with industry during 2022 and/or 2023: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.